ISPOR - EE712 Economic and Clinical Impact of Immunization With Nirsevimab Among All Infants in Their First RSV Season Against Standard of Care in Japan

Full Text

EE712 Economic and Clinical Impact of Immunization With Nirsevimab Among All Infants in Their First RSV Season Against Standard of Care in Japan

Abstract

Authors

C Tadera S Soudani X Wang

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now